Netherlands Diabetes Market, By CGM, SMBG, Insulin Pen & Pump, Companies

1
Netherlands Diabetes Market
Netherlands Diabetes Market
2
Report Description and Highlights
Netherland has observed a rise in the prevalence
of type 2 diabetes during the last decade. As the
Dutch population is ageing and the incidence of
obesity is a significant risk factor for diabetes
is increasing, survival is improving, and
multiple screening initiatives are implemented in
the Netherlands. In 2013, nearly half the Dutch
population suffered from at least one chronic
disorder. One of the disorders with a high
disease burden and reduction in quality of life
is diabetes mellitus. Netherlands Diabetes Market
is gardened to reach USD 4.48 Billion by the
year 2025.
Netherlands Diabetes Market
3
Netherlands Diabetes Market
In the Netherlands, the prevalence of diabetes
mellitus (DM) is increasing rapidly. Netherlands
care for diabetes is mainly concentrated in
primary health care, with responsibility for most
aspects of care in the hands of general
practitioners. In general, primary health care in
The Netherlands provides a good standard of care
for subjects with DM. Another point of concern is
the rise in the prevalence of obesity, leading to
a vast increase in subjects with metabolic
syndrome. DM (diabetes mellitus) care and its
provision will continue to play an important role
in health care in The Netherlands. The market of
Continuous Glucose Monitoring (CGM) Device, Self
Monitoring Blood Glucose Device, Insulin Pen and
Insulin Pump are growing due to the rising
awareness for diabetes in Netherland. Diabetes
care in The Netherlands has reached a high level
of quality, but there is still an opportunity for
further improvement. Not only is it a medical
challenge but at least as much a burden for the
Dutch economy and society. To fight with these
risk factors, the Netherlands rolled out national
health programs. In 2018, The National Prevention
Agreement which was approved and it sets out
ambitious goals to make the Netherlands healthier
by 2040, but it was in March 2019 that they are
still far from reach.
Netherlands Diabetes Market
4
Netherlands Diabetes Market
Over the past decade, the National Action program
Diabetes (NAD) was implemented in the
Netherlands. It is aimed to introduce the Care
Standard (CS) for diabetes using a specific
implementation plan and to pilot in several
regions. In the year December 2019, Roche
received CE Mark for its Accu-Chek SugarView app.
Accu-Chek SugarView is the first app that checks
the blood glucose ranges by taking pictures with
the Smartphone camera without the requirement for
a blood glucose meter.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lnetherlands-diabetes-market-p.php
Netherlands Diabetes Market
5
Netherlands Diabetes Market
Renub Research report titled Netherlamds
Diabetes Market Forecast, By Continuous Glucose
Monitoring (CGM Market by Components, Glucose
Sensor, Transmitter, CGM User, Reimbursement),
Self Monitoring Blood Glucose Device Analysis
(SMBG Market by, Test Strips, Lancet, Meter,
Blood Glucose Device Users Reimbursement)
Insulin Pen Analysis (User, Types Disposable,
Reusable and Smart Insulin Pen, Insulin Pen
Needle Market, Reimbursement Policies), Insulin
Pump Analysis- (Users, Market Differentiation
Points of Insulin Pump Products, Training Model
for Patients HCP, Reimbursement Policies)
Companies (B. Braun Melsungen AG, Eli Lilly and
Company, Artsana S.p.A, BD, Novo Nordisk A/S,
Owen Mumford Ltd, Ypsomed AG, Medtronic, Insulet
Corporation, LifeScan Inc., Abbott Laboratories,
Dexcom Inc and Roche) provides a complete
analysis of Netherland Insulin Delivery Devices
Market.
Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urlnetherlands-diabetes-market-p.php
Netherlands Diabetes Market
6
Netherlands Diabetes Market

• Segments Market based on Devices
• 1.    Continuous Glucose Monitoring (CGM)2.  
   Self Monitoring Blood Glucose (SMBG)3.  
   Insulin Pen4.    Insulin Pump
• Netherlands Diabetes Sub-Segment Analysis
• Continuous Glucose Monitoring (CGM)
• 1.1.    Glucose Sensor Market Forecast1.2.  
   CGM Transmitter Market Forecast1.3.    CGM
  User1.4.    CGM Reimbursement

Netherlands Diabetes Market
7
Netherlands Diabetes Market
Forecast for Netherlands Diabetes Market Share
() - by Segments (2020 - 2026)
Source Renub Research Analysis Note
These are dummy figures actual data given in the
report
Netherlands Diabetes Market
8
Netherlands Diabetes Market
2. SMBG 2.1.    Test Strips Market and Forecast
2.2.    Lancet Market and Forecast2.3.  
 Meter Market and Forecast 2.4.    Blood
Glucose (SMBG) Users2.5.    Blood Glucose
Devices Reimbursement   3. Insulin Pen
Market 3.1.    Disposable Insulin Pen
3.2.    Reusable Insulin Pen3.3.    Smart
Insulin Pen 3.4.    Insulin Pen Needle
Market3.5.    Insulin Pen Users 3.6.  
 Reimbursement Policies 4. Insulin Pump
Market 4.1.    Insulin Pump Market 4.2.  
 Insulin Pump Users4.3.    Insulin Pump
Products 4.4.    Reimbursement Policies
Netherlands Diabetes Market
9
Netherlands Diabetes Market
All the 14 Companies Studied in the Report have
been Studied from 3 Points     Company
Overview    Recent Developments    Financial
Insight Company Analysis 1.    B. Braun
Melsungen AG 2.    Eli Lilly and Company3.  
 Artsana S.p.A 4.    BD5.    Novo Nordisk
A/S 6.    Owen Mumford Ltd7.    Ypsomed
AG 8.    Medtronic9.    Insulet
Corporation 10.    LifeScan Inc.11.    Abbott
Laboratories 12.    Roche13.    Dexcom Inc
Netherlands Diabetes Market
10
Netherlands Diabetes Market
Browse Related Report Sweden Diabetes
Market Germany Diabetes Market Contact Us Tel
1-678-302-0700 (US), 91-120-421-9822
(INDIA) Email info_at_renub.com
Netherlands Diabetes Market